Phase II study of neoadjuvant FLOT and chemoradiation for trimodality therapy of esophageal/GEJ adenocarcinoma. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium.
Discover how proteomics data analysis and bioinformatics tools enhance mass spectrometry workflows for robust findings.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results